Pre-emptive Rights in Funding Rounds: Mechanics, Waivers

Every time you raise a new round, two separate legal frameworks are activated simultaneously. The first is statutory: Section 62 of the Companies Act 2013 gives every existing equity shareholder a legal right to participate in any fresh share issuance before shares are offered to new investors. The second is contractual: the pre-emption clause in your SHA gives your investors a specifically defined, privately negotiated version of that same right, with mechanics that are almost always more favourable to the investor than what the statute alone would require. Most founders treat these as one and the same. They are not. Getting confused between them is the source of more closing delays and cap table disputes than almost any other single issue in Indian funding rounds.

Layered on top of both is a third question that almost nobody addresses cleanly: whether the SHA pre-emption clause is even enforceable against the company, or only against the other signatories. The answer turns on whether the Articles of Association (AoA) reflects the SHA. Indian courts have been consistent on this point, and the consequences of ignoring it are severe.

This article maps every layer: statutory, contractual, AoA enforceability, FEMA compliance for foreign holders, waiver mechanics, pay-to-play consequences, and the SEBI September 2025 amendment. It is structured for founders who need to understand exactly what they have signed, what to push back on, and how to manage the process at each subsequent close.

What are pre-emptive rights in funding rounds?

What exactly does a pre-emptive right give an investor in a funding round?

A pre-emptive right gives an existing shareholder the first opportunity to subscribe to newly issued shares of the company before those shares are offered to an incoming investor, in proportion to the shareholder’s existing holding on a fully diluted basis. The right is triggered by the company’s decision to issue new securities. If the holder exercises the right, their ownership percentage stays constant after the new round closes. If they decline, they get diluted in proportion to the size of the new issuance.

In practice, an investor holding 12% of your company on a fully diluted basis going into a Series B would be entitled under a standard pro-rata pre-emption clause to subscribe to 12% of the new shares being issued in that round, at the same price and on the same terms as the incoming Series B investor. They are not obligated to exercise. The right gives them the option, not the requirement, to maintain their stake.

The right matters more at later stages than at early ones. An angel who invested ₹50 lakhs at seed for 5% of your company faces a rounding-error dilution in a Series A. That same 5% in a company heading toward IPO at a ₹5,000 crore valuation is worth ₹250 crore. Pre-emption rights are the mechanism that lets early investors protect that compounding value, and the mechanism founders must manage carefully at every subsequent close.

The statutory layer: Section 62 of the Companies Act 2013

How Section 62 creates a mandatory pre-emption floor for Indian companies

Section 62(1)(a) of the Companies Act 2013 is the statutory source of pre-emptive rights in India. It mandates that any company (private, public, listed, or unlisted) that proposes to increase its subscribed share capital by allotting further shares must first offer those shares to existing equity shareholders in proportion to their paid-up shareholding. The offer must be made through a letter of offer, and shareholders must be given a minimum of 15 days and a maximum of 30 days to accept.

This is a mandatory compliance requirement, not a default that can be excluded by silence. It replaced the equivalent provision in Section 81 of the Companies Act 1956, with a significant structural change: where the old law contained a two-year exemption window from the date of incorporation, Section 62 applies from the first day of a company’s existence. Every fresh share allotment, regardless of stage, falls within its scope.

Under Section 62(1)(a), before you allot CCPS or equity shares to an incoming investor, you must technically offer the same shares first to your existing equity shareholders in proportion to their holdings. If you proceed directly to allotment without either completing that process or routing through one of the statute’s alternative pathways, the allotment may be challenged as procedurally invalid.

Three lawful pathways exist under the statute to avoid the standard rights issue process:

Table 1: Section 62 pathways for share allotment in VC funding rounds

Pathway	Statutory basis	What it requires	Used when
Rights issue	Section 62(1)(a)	Letter of offer, 15-30 day window, shareholder response	Rarely used in VC rounds; operationally slow
Special resolution	Section 62(1)(c)	Shareholders pass special resolution authorising allotment to named persons at specific price	Most common in VC rounds; enables private placement to incoming investor
Employee stock options	Section 62(1)(b)	Board resolution, ESOP scheme compliant with Rule 12	ESOP pool issuances only

For almost every Indian VC funding round, the route taken is Section 62(1)(c): a special resolution is passed at an EGM or by postal ballot, specifically authorising the allotment of shares to the incoming investor at the agreed price and on the agreed terms. The effect of that special resolution is that existing shareholders, as a class, have approved the deviation from the standard rights issue process. This does not mean individual shareholders have waived their contractual pre-emption rights under the SHA. That distinction matters enormously.

Section 62 and preference shareholders: a live interpretive debate

Section 62(1)(a) explicitly grants pre-emption rights to equity shareholders. Preference shareholders are not mentioned. The ICSI has historically taken the position that preference shareholders do not have statutory pre-emption rights under Section 62. In Indian VC-funded companies where investors typically hold CCPS and founders hold equity, this creates an asymmetry: founders as equity shareholders technically have Section 62 statutory rights; investors as CCPS holders technically do not, unless those rights are contractually granted in the SHA.

This is exactly why investor counsel drafts an explicit SHA pre-emption clause. The statutory right for CCPS holders is uncertain. The contractual right, once documented in the SHA and accepted by all parties, is not. The contractual right in the SHA, however, has its own enforceability constraint, which the next section explains.

The AoA enforceability gap: why an SHA pre-emption clause without AoA mirroring is only half a right

Is a pre-emption clause in the SHA enforceable against the company itself?

Not automatically. This is the most consistently underestimated issue in Indian funding round documentation, and Indian courts have been clear about it since 1992.

In V.B. Rangaraj v. V.B. Gopalakrishnan (1992), the Supreme Court held that a share transfer restriction in an SHA that was not reflected in the AoA was not binding on the company, even though it was valid as a contract between the shareholders who signed it. The reasoning: the AoA is the company’s constitutional document under Section 10 of the Companies Act, and it binds both the company and all shareholders. A private SHA is a contract only between its signatories. Where the two conflict, the AoA prevails.

The Gujarat High Court applied the same principle to pre-emption rights specifically in Mafatlal Industries Ltd. v. Gujarat Gas Co. Ltd. (1997), holding that pre-emptive rights of shareholders in a public company SHA were not enforceable because they were not incorporated in the AoA. The Delhi High Court reinforced this in World Phone India Pvt. Ltd. v. WPI Group Inc. (2013), where SHA governance rights not reflected in the AoA were held non-binding on the company.

The practical consequence for a founder:

An investor whose pre-emption right is in the SHA but not mirrored in the AoA can sue co-signatories (other investors, founders) for breach of the SHA if the right is ignored. But they cannot compel the company to unwind an allotment, issue additional shares, or void a closing. The company, acting through its board and in accordance with its AoA, is not bound by an SHA clause that the AoA does not also contain.

This distinction matters most in two scenarios. First, where the company has been through multiple rounds and the AoA has not been updated consistently with each SHA amendment. Second, where the SHA includes a pre-emption clause that is more detailed or broader than what the AoA specifies, in which case the AoA version prevails for company-level enforcement.

The fix is straightforward but must be done at every round:

At each funding round close, when the SHA is amended or restated to reflect the new investor’s rights, the AoA must be simultaneously amended by special resolution to incorporate the pre-emption clause in materially the same terms. The AoA amendment requires a special resolution under Section 14 of the Companies Act 2013, filed with the ROC in Form MGT-14 within 30 days. Where founders are in a rush to close and are managing documents themselves, the AoA amendment is the step most likely to be deferred or forgotten. It is also the step that creates the enforceability gap.

Treelife’s SHA vs. SPA and SSA guide and liquidation preference article both flag this for their respective clauses. Pre-emption is no different, and the case law on it is if anything more established.

The contractual layer: how the SHA pre-emption clause works

How is a pre-emption right drafted in a standard Indian SHA?

An SHA pre-emption clause in an Indian venture deal typically covers six elements:

1. Trigger events. What share issuances activate the right. Standard drafting covers equity shares, CCPS, compulsorily convertible debentures (CCDs), warrants, and any other convertible instruments. Watch for drafting that limits the trigger to “equity shares” only. An investor relying on that clause gets no protection when the company issues CCPS in a later round, which is the instrument used in almost every Indian VC deal.

2. Pro-rata entitlement. The investor’s right to subscribe to its proportionate share of the new issuance, calculated on a fully diluted basis. Fully diluted means including all outstanding CCPS on an as-converted basis, all ESOP grants (vested and unvested), all warrants, and all other convertible instruments. The difference between issued capital and fully diluted capital can be 20-30% in a company with a large ESOP pool and multi-round CCPS history, meaning the denominator, and therefore each investor’s pro-rata percentage, is materially affected by how “fully diluted” is defined.

3. Notice period. The company must send a notice to each pre-emption right holder detailing the terms of the new round (number of shares, price, class, and key economic terms) and give them a defined period (typically 10 to 20 days in Indian SHAs, sometimes longer) within which to confirm their intent to exercise.

4. Exercise mechanics. How the investor communicates their election and commits funds. Standard Indian SHA drafting requires written confirmation within the notice period, followed by payment of subscription money on or before the closing date.

5. Oversubscription mechanics. What happens if one or more investors exercise and one or more do not. Unexercised portions are typically reallocated to exercising investors in proportion to their own holdings (a “secondary pro-rata”), and any remaining unsubscribed shares go to the incoming investor.

6. Carve-outs. Categories of share issuances to which pre-emption rights do not apply. Market-standard Indian carve-outs include ESOP issuances, bonus shares, conversions of previously issued instruments, and shares issued as merger consideration.

Super pro-rata rights: what they are and why founders must push back

A standard pro-rata pre-emption right lets an investor maintain their current percentage. A super pro-rata right lets an investor increase their percentage. If Investor X holds 15% and has a super pro-rata right to 20%, a Series B round with ₹50 crore of new shares must reserve enough shares for Investor X to go from 15% to 20%, before any other allocation is made. The dilution that would ordinarily fall on the new investor falls instead on founders and other existing shareholders.

Super pro-rata rights appear in Indian SHAs with increasing frequency, particularly in deals where a lead investor is negotiating hard on round mechanics after a competitive seed raise. Push back on super pro-rata hard at term sheet stage. By the time the SHA draft arrives, it has already been agreed in principle.

The threshold question: who gets pre-emption rights?

Not every shareholder in an Indian startup SHA gets pre-emption rights. The clause typically grants the right to investors above a defined threshold, commonly investors holding more than 1% of the fully diluted share capital, or investors who have invested more than a defined rupee amount. Below-threshold holders get diluted without any right to participate.

This is market-standard and operationally reasonable. Founders should pay attention to: (a) whether the threshold is set as a percentage or a rupee amount, since a percentage threshold can exclude early angels who have been diluted by later rounds even if they are commercially important, and (b) whether the threshold is re-tested at each round or fixed at the time of first investment.

Worked example: pre-emption in a ₹30 crore Series B

A company has the following pre-Series B cap table (fully diluted):

Table 2: Pre-Series B cap table

Shareholder	Shares	% (FD)
Founders	45,00,000	45.0%
Seed VC (Angel Fund A)	15,00,000	15.0%
Series A VC	25,00,000	25.0%
ESOP pool (granted + ungranted)	15,00,000	15.0%
Total	1,00,00,000	100.0%

The company is raising ₹30 crore at a post-money valuation of ₹150 crore, issuing 25,00,000 new CCPS to the Series B investor. Both Angel Fund A and the Series A VC have pro-rata pre-emption rights. The Series A VC is a Singapore-registered fund, a foreign investor for FEMA purposes.

Angel Fund A’s entitlement: 15% × 25,00,000 = 3,75,000 shares (₹4.5 crore). Series A VC’s entitlement: 25% × 25,00,000 = 6,25,000 shares (₹7.5 crore).

Scenario A: both exercise in full. The Series B investor gets only 14,00,000 of its target 25,00,000 shares. If the round size is fixed, the company must issue additional shares to give the Series B investor what they were promised, which increases dilution to founders. Alternatively, the round must be restructured. This scenario is far more common in live closings than founders expect.

Scenario B: only Series A VC exercises, Angel Fund A declines. Angel Fund A’s unexercised 3,75,000-share entitlement goes first to Series A VC under the oversubscription mechanic, then the remainder to the Series B investor. Founders are diluted by the declining investor’s unexercised portion.

Scenario C: Angel Fund A cannot exercise due to SEBI AIF constraints. See the SEBI September 2025 section below. Their regulatory inability to exercise does not give founders or other shareholders those shares. They flow to the incoming Series B investor.

Scenario D: Series A VC (foreign investor) exercises. The exercise constitutes fresh FDI. Before shares can be allotted, the company must obtain a fresh valuation from a SEBI-registered Merchant Banker or CA, confirm the subscription price meets or exceeds FMV under the NDI Rules, and file Form FC-GPR within 30 days of allotment. See the FEMA section below for the full compliance sequence.

FEMA compliance when a foreign investor exercises a pre-emption right

This is the gap that trips up rounds with foreign investors. A foreign investor exercising a pre-emption right is making a fresh investment in an Indian company. That investment is governed by the Foreign Exchange Management (Non-debt Instruments) Rules, 2019 (NDI Rules) and the RBI Master Direction on Foreign Investment in India (updated January 2025) in exactly the same way as any other FDI. The SHA pre-emption clause does not create a FEMA exemption.

What FEMA compliance steps fire when a foreign investor exercises?

Step 1: Sectoral cap headroom check. Before confirming exercise, the company must verify that the foreign investor’s increased holding after exercise does not breach the FDI sectoral cap applicable to the company’s business. For sectors at 100% automatic route (most tech and SaaS companies), this is rarely a problem. For companies in sectors with caps (fintech regulated by RBI, insurance, broadcasting, defence), the check is mandatory and must be done before the pre-emption notice period expires.

Step 2: Valuation. Under Rule 21 of the NDI Rules, shares issued to a non-resident investor must be priced at or above fair market value (FMV) as determined by a SEBI-registered Category I Merchant Banker or a Chartered Accountant using internationally accepted valuation methodologies. The valuation must be current, obtained before the board meeting that approves allotment. A valuation report used for the incoming investor’s subscription in the same round can typically be used for the exercising foreign investor’s subscription as well, provided the allotment date is within a reasonable window of the valuation date. If the round timeline stretches, a fresh valuation may be needed.

Step 3: Inward remittance and FIRC. The exercising foreign investor must remit subscription funds through a SEBI-registered Authorised Dealer (AD) bank. The AD bank issues a Foreign Inward Remittance Certificate (FIRC), which is a mandatory document for the FC-GPR filing. Funds cannot be netted, set off, or routed through an escrow without specific RBI approval.

Step 4: Board resolution for allotment. A separate board resolution is required for allotment of shares to the foreign investor, even if the special resolution under Section 62(1)(c) already covers the round. The board resolution must record the allotment price, the number of CCPS allotted, and the basis of pricing compliance.

Step 5: FC-GPR filing. Form FC-GPR must be filed on the RBI FIRMS portal within 30 days of the date of allotment. The filing requires: the FIRC, the valuation certificate, the board resolution for allotment, the KYC documents for the foreign investor, and the CS certificate confirming compliance. A delay in FC-GPR filing is a compoundable contravention under Section 13 of FEMA 1999. Late submission fees (LSF) apply automatically and are computed by the FIRMS portal.

Step 6: FLA return update. The company’s Annual Foreign Liabilities and Assets (FLA) return, filed with the RBI by 15 July each year on the FLAIR portal, must reflect the updated foreign shareholding arising from the pre-emption exercise in the relevant financial year.

Table 4: FEMA compliance sequence for a foreign investor exercising pre-emption rights

Step	Action	Deadline	Filed with
1	Sectoral cap headroom check	Before notice period expires	Internal; documented
2	FMV valuation certificate	Before board meeting for allotment	SEBI-registered MB or CA
3	Inward remittance via AD bank; obtain FIRC	Before allotment date	AD bank
4	Board resolution for allotment	On allotment date	Company records; ROC via PAS-3
5	FC-GPR filing on FIRMS portal	Within 30 days of allotment	RBI via AD bank
6	FLA return update	By 15 July of the relevant year	RBI FLAIR portal

The renunciation angle under FEMA adds a further complication. If a resident shareholder renounces their pre-emption entitlement in favour of a non-resident (see the renunciation section below), the pricing exemption that normally applies to rights issues under Rule 7 of the NDI Rules does not apply. Instead, Rule 7A of the NDI Rules (inserted by the 2020 amendment) makes pricing under Rule 21 applicable to shares allotted to a non-resident renouncee. This means the FMV valuation requirement applies regardless of whether the round price was already negotiated at arm’s length.

A common misconception Treelife sees in multi-investor rounds: founders assume that because the main incoming investor’s subscription was priced and documented correctly, the pre-emption exercise by an existing foreign investor does not need its own FEMA compliance steps. It does. The two are separate allotment events, both of which require their own valuation confirmation, FIRC, and FC-GPR.

Renunciation under Section 62(1)(a)(ii): transferring the right rather than waiving it

Waiver is not the only option available to a pre-emption right holder who does not want to exercise. Under Section 62(1)(a)(ii) of the Companies Act 2013, an existing shareholder can renounce their right in favour of any other person, including a person who is not currently a shareholder of the company. This is distinct from waiver, where the unexercised entitlement simply falls back into the pool.

Renunciation is used when: an existing investor wants to allow a specific new co-investor to come in via their own entitlement rather than through a fresh allotment; or where the original investor does not have the capital to exercise but wants to redirect the economic value of their right to a designated third party.

In a startup funding context, renunciation is relatively uncommon but operationally important to understand because it changes the compliance picture in two respects.

First, for domestic transactions: a shareholder can renounce in favour of any person, subject to whatever restrictions the AoA places on renunciation. Unlisted private companies can restrict or prohibit renunciation in their AoA. Where the AoA is silent, renunciation is permitted. The renounced shares are allotted to the renouncee at the same terms as the original offer.

Second, for cross-border transactions: if a resident shareholder renounces in favour of a non-resident, Rule 7A of the NDI Rules applies. The pricing exemption for rights issues under Rule 7 does not apply to renounced portions acquired by non-residents. The non-resident renouncee must subscribe at or above FMV per Rule 21, the company must obtain a fresh valuation, and all FEMA compliance steps (FIRC, FC-GPR, FLA update) follow as they would for any other FDI allotment.

The key distinction: waiver means the entitlement disappears and shares go to the incoming investor under the oversubscription mechanic or directly. Renunciation means the entitlement moves to a named third party who then subscribes in their own right. Founders should confirm in every closing which existing investors are waiving and which (if any) are renouncing, because the compliance footprint is different.

The SEBI September 2025 amendment: what changed for angel fund pre-emption

SEBI notified the Securities and Exchange Board of India (Alternative Investment Funds) (Second Amendment) Regulations, 2025 in September 2025, substantially overhauling the angel fund framework. The relevant change for pre-emption: prior to the amendment, a SEBI informal guidance response to a registered angel fund (March 2025) had clarified that angel funds could not exercise pre-emptive rights in investee companies that no longer met the DPIIT startup criteria. An angel fund is a Category I AIF and is authorised to invest only in DPIIT-recognised startups. Once a portfolio company graduates past DPIIT eligibility (by exceeding 10 years from incorporation, or by crossing ₹100 crore in annual turnover, or by becoming publicly listed), the fund loses the regulatory basis to make further investments, including through pre-emption rights exercises.

The September 2025 amendment addressed this problem partially. Follow-on investments in non-startup portfolio companies are now permitted, subject to two conditions: the post-issue shareholding percentage of the angel fund must not exceed its pre-issue percentage, and total investment in any single investee company must not exceed ₹25 crore in aggregate. An angel fund can exercise pre-emption rights to maintain (but not increase) its stake in a company that has graduated from DPIIT startup status, as long as the ₹25 crore aggregate cap is not breached.

If your seed-stage angel fund investors hold their participation through a SEBI-registered angel fund structure and your company is approaching or has crossed the DPIIT graduation threshold, check before your next round closes whether those investors can legally exercise their pre-emption rights. If they cannot, or if the ₹25 crore cap has already been reached, their contractual SHA pre-emption right exists but is unenforceable against the regulatory constraint. The unexercised allocation flows to the incoming investor, not back to founders.

Fund managers who backed companies at the verge of DPIIT graduation before March 2025 are the most exposed. Their SHA pre-emption clauses are intact, but SEBI’s regulatory framework, even as amended in September 2025, may constrain their ability to exercise those rights to the extent they originally anticipated.

Waiver mechanics: the three types founders need at every closing

Obtaining valid waivers of pre-emptive rights from existing investors is a closing condition in every Indian VC funding round. The process is operationally unglamorous and frequently left to the last week before closing, which is when it creates the most disruption.

Type 1: Advance SHA waiver (prospective waiver)

The most common structure in Indian SHAs is a clause that conditions the pre-emption right on the company completing a specified notice procedure and a specified exercise window, and states that failure to confirm exercise within that window constitutes a waiver with respect to the relevant issuance. This is a prospective, conditional waiver: the investor does not sign a separate waiver document at each closing; instead, they simply fail to respond within the exercise window, and the SHA’s own mechanics treat that non-response as waiver.

The enforceability question under Indian law: a waiver of a right under a contract is governed by Section 63 of the Indian Contract Act 1872. An advance contractual mechanism that deems non-response as waiver is enforceable between sophisticated commercial parties where the notice procedure was properly followed. The risk arises precisely where the notice procedure was not followed. If the company proceeds to allotment without issuing the pre-emption notice in compliance with the SHA, the deemed-waiver mechanism does not activate and the allotment can be challenged.

Type 2: Transaction-time individual waiver

Best practice in Indian funding rounds is to supplement the advance SHA mechanism with a separate, transaction-specific waiver letter signed by each pre-emption right holder at or before closing. This document identifies the specific round by name, date, and instrument type; states the total number of new shares being issued and the subscription price; confirms the signing investor has received notice as required under the SHA; records their election not to exercise, or their partial exercise amount; and releases the company from any obligation arising from the SHA pre-emption clause with respect to this specific issuance.

The transaction-time individual waiver is the most commonly used in practice. It requires the investor to sign, which means their legal counsel is involved, which means any ambiguity about the scope of the pre-emption right gets flushed out before closing rather than after.

Type 3: Class waiver via SHA amendment

Where the SHA specifies a threshold (e.g., 65% or 75% of investors by share count) for amending investor rights, a class-level waiver can be obtained by reaching that threshold. This approach is used in rounds where one or two investors cannot or will not sign individual waivers. If the SHA’s amendment mechanic requires unanimous consent for changes affecting individual economic rights, a class waiver will not work. Review the amendment and waiver provisions of your existing SHA before assuming class-level waivers are available.

Table 3: Pre-emption waiver types compared

Waiver type	How obtained	Indian-law strength	Best used when
Advance SHA waiver (deemed)	Follows automatically from non-response to notice	Strong if notice procedure followed correctly	Standard; must always be done regardless of other waiver types
Transaction-time individual waiver	Separate letter signed by each investor	Strongest; investor explicitly confirms	Every closing; default mechanism
Class waiver via SHA amendment	Majority of class (if SHA permits)	Works only if amendment mechanic allows it	One investor unreachable or refusing; round must close

The notice-confidentiality tension founders miss

Sending a valid pre-emption notice requires disclosing the terms of the new round (incoming investor identity, price, instrument type, key economic terms) to all existing pre-emption right holders. Term sheets are almost always confidential. Most term sheets include a confidentiality clause binding the company, not just the founders personally. Sending a pre-emption notice before term sheet confidentiality expires, without a carve-out, is a technical breach of the term sheet.

The fix is straightforward and should be negotiated at term sheet stage: the confidentiality clause must include an explicit carve-out permitting the company to disclose round terms to existing shareholders for the purpose of complying with pre-emption notice obligations under existing SHAs. Treelife builds this carve-out into every term sheet we review. Founders managing their own term sheet review without legal support regularly miss it, which then creates a situation where the pre-emption notice cannot be sent until confidentiality expires, compressing the closing timeline by the full duration of the notice period.

Pay-to-play: what investors lose by not exercising

Most Indian SHA discussions focus on what investors gain by exercising pre-emption rights. Fewer founders and advisors understand the consequences that flow in the other direction when an investor elects not to exercise, particularly in down rounds.

A pay-to-play provision, increasingly present in SHAs drafted by global VC counsel and now appearing in Indian deals, links pre-emption exercise to the retention of other investor rights. The structure: if an investor fails to participate in a new round (particularly a down round) at or above a defined minimum percentage of their pro-rata entitlement, they forfeit some or all of their anti-dilution protection, their preferred stock may be converted to a lower class of shares, or other protective provisions degrade.

The economic logic is investor-alignment: it prevents a situation where early investors benefit from anti-dilution protection in a down round while declining to put fresh capital into the same company. Pay-to-play provisions are a mechanism to ensure that anti-dilution is available to investors who continue to back the company, not to those who step back when conditions are difficult.

For founders, pay-to-play provisions are paradoxically useful in down rounds. They create financial pressure on investors to participate in the new round (which reduces the capital the founders must source from other parties) and, where investors choose not to participate, they reduce the investor’s ongoing preferential rights, which directly benefits founders at exit. This is one of the few provisions in a term sheet that serves founder interests in adversity.

For investors negotiating their initial investment terms, the interaction between pay-to-play and pre-emption must be read together. An investor who signs a SHA with pay-to-play linked to pre-emption exercise is implicitly committing to maintain reserves for future rounds. Investors who cannot commit to follow-on capital should resist pay-to-play provisions at the term sheet stage.

Indian SHAs do not yet universally contain pay-to-play provisions. They remain more common in deals involving US-domiciled funds investing into Indian companies, but their frequency is increasing as global VC practice migrates into Indian deal documentation. Founders negotiating at seed and Series A should review whether the draft SHA contains this linkage and understand it before signing.

Carve-outs: market standard vs. negotiated

Pre-emption clauses in Indian SHAs almost universally exempt certain categories of share issuances from triggering the right. Some exemptions are market standard. Some are founder-negotiated concessions that are worth fighting for.

Market-standard carve-outs (expect these; do not give more)

• Shares issued on conversion of previously issued instruments (CCPS, CCDs, warrants) already in place at the time the SHA was signed, as these sit in the fully diluted cap table and are not new issuances
• Bonus shares and stock splits
• Shares issued under the company’s ESOP scheme, up to the approved pool size
• Shares issued as consideration in a statutory merger or acquisition approved by NCLT

Founder-negotiated carve-outs (push for these)

• Bridge financing: shares or instruments issued in a bridge round of up to a specified amount (typically ₹5-10 crore in early-stage companies) where the company requires capital between formal rounds. Without a bridge carve-out, every bridge note or convertible triggers the full pre-emption process, with all the notice periods and investor coordination that entails.
• Strategic investor issuances: shares issued to a named strategic investor where the strategic value of the relationship makes it impractical to offer pre-emption to financial investors at the same terms.
• Government or quasi-government schemes: shares issued under SIDBI schemes, government co-investment platforms, or GIFT City fund structures where the counterparty’s identity and terms are prescribed by a regulatory scheme rather than negotiated commercially.

What happens in a down round

A down round is the highest-stakes scenario for pre-emption rights. Investors who have anti-dilution protection will see their CCPS conversion ratios adjusted upward if the new round price is lower than their entry price. That anti-dilution adjustment mechanically increases their percentage post-round, but it is a formula-based computation, not an exercise of pre-emption rights.

Separately, those same investors may have strong economic motivation to exercise their pre-emption rights in the down round: participating at the lower price lets them acquire additional shares at a discount, which improves their blended entry economics. In a down round, pre-emption rights and anti-dilution rights work in combination: anti-dilution adjusts existing holdings, and pre-emption allows additional acquisition at the new (lower) price.

For founders in a down round, the combination is particularly dilutive. A Series A VC with weighted-average anti-dilution and pro-rata pre-emption can, in a stressed scenario, end up with a materially higher percentage post-round than they held pre-round, without investing proportionally to that increase. Any SHA that couples full-ratchet anti-dilution with super pro-rata pre-emption rights is structurally designed to shift the majority of down-round cost onto founders. This is why negotiation on anti-dilution and super pro-rata at term sheet stage must be treated together, not in isolation.

Where pay-to-play provisions exist, the down round also tests whether non-exercising investors lose their anti-dilution protection. This can produce a counter-intuitive outcome: an investor who exercises pre-emption in the down round retains full anti-dilution protection and benefits from both the formula adjustment and the below-price acquisition. An investor who does not exercise loses anti-dilution protection but also avoids putting in fresh capital. Which outcome is better for the investor depends on their conviction and reserves. Which outcome is better for founders depends on how much they need the investor’s capital vs. how much they want to reduce that investor’s ongoing preferential rights.

How pre-emption interacts with the Section 62 special resolution

When a company passes a special resolution under Section 62(1)(c) to allot shares to an incoming investor, it satisfies the statutory requirement for that specific allotment. The special resolution does not override the SHA pre-emption clause. The two operate on different tracks.

The special resolution is a corporate governance act that authorises the board to allot shares without going through the Section 62(1)(a) rights issue procedure. It does not constitute a waiver by any individual investor of their contractual SHA rights. An investor who votes in favour of the special resolution, or whose nominee director votes in favour at the board level, has not thereby waived their SHA pre-emption right unless the SHA specifically provides for that effect.

In practice, the special resolution is passed at the EGM and the SHA waivers are obtained simultaneously at closing. Treating them as substitutes for each other is a legal error that creates closing risk. Treelife consistently sees this confusion in deals where founders are managing the closing process themselves: the EGM passes the special resolution, allotment happens, and it is only months later, when a prior investor raises a breach of SHA claim, that the missing waiver letters surface as a problem.

How pre-emption rights layer across rounds: the incoming investor’s position

Every funding round closing both resolves existing pre-emption rights and creates new ones. The incoming Series B investor who subscribed to CCPS at closing does not just bring capital. They bring a fresh set of SHA rights, including pro-rata pre-emption rights in the Series C. Where the SHA grants super pro-rata to the Series B investor, those rights apply from the moment of closing.

The cumulative effect of layering pre-emption rights across multiple rounds is one of the most underestimated cap table dynamics in Indian startups. By Series C, a company may have: seed angel investors with pro-rata rights (possibly subject to SEBI AIF constraints), Series A VC with pro-rata rights (and potentially super pro-rata), Series B VC with pro-rata rights, and a fresh Series C incoming investor. Every round close must map this entire rights stack before the pre-emption notice goes out.

Two specific problems arise from this layering. First, the oversubscription mechanic becomes more complex with each round: if multiple investors exercise and the total exercise exceeds the round size, the allocation among exercising investors must be computed carefully, and the SHA’s oversubscription waterfall may not be clear. Second, the notice process becomes more cumbersome: a pre-emption notice must go to every qualifying holder, each with potentially different notice periods, thresholds, and exercise mechanics negotiated at different points in time under different SHA versions.

The incoming investor’s pre-emption rights also create an immediate negotiation dynamic for founders: if the Series B investor insists on super pro-rata rights in the Series C, the founder’s ability to bring in a new Series C lead investor on clean economics is constrained from day one of the Series B closing. This is a term sheet negotiation point, not a closing negotiation point. By closing, it is settled.

The notice procedure: what must be in a pre-emption notice

A pre-emption notice under the SHA must typically contain:

Round identification: name of the round, proposed closing date, and identification of the incoming investor (or, where confidentiality is required, the investor category, subject to the term sheet confidentiality carve-out discussed above).

Terms of issuance: number of new shares, class of shares, subscription price per share, pre-money valuation, and any material economic terms (liquidation preference, dividend rights, anti-dilution basis) that differ from existing CCPS terms.

Entitlement calculation: the specific number of shares the recipient is entitled to subscribe, calculated on the fully diluted basis specified in the SHA, with the calculation shown.

Exercise deadline: the date (conforming to the SHA’s notice period requirement) by which written exercise confirmation must be received. SHA pre-emption clauses sometimes specify 10 days in time-sensitive rounds, which is consistent with contractual freedom between the parties even if it is shorter than the Section 62 statutory floor of 15 days for a rights issue.

Exercise mechanics: bank account and payment details for subscription money in the event of exercise, and the confirmation letter format required.

Sending an inadequate notice (one that omits the calculation, the pricing basis, or the exercise deadline) invalidates the deemed-waiver mechanism. An investor who later claims they were not given adequate notice has a credible argument if the notice document itself is incomplete.

Practitioner note

In the last 18 months, the pattern we see repeatedly in Series A and Series B closings is a conflict between the pre-emption notice period in the SHA and the timeline pressure from an incoming investor who wants to close in 30 to 45 days. A 20-day notice period, combined with investor counsel review time and a shareholder meeting for the special resolution, leaves almost no room for delays.

The solution is not to shortcut the notice. It is to structure the closing timeline from day one around the pre-emption process. Identify the full pre-emption rights map at term sheet stage: who holds rights, what the notice periods are, whether any SEBI regulatory constraints apply, and whether any holders are foreign investors triggering FEMA compliance steps. Send pre-emption notices on the day the term sheet is signed, not the day the SHA is finalised. Collect conditional exercise elections or non-exercise confirmations from investors in parallel with SHA negotiation.

When this is done correctly, the pre-emption process runs in parallel with drafting rather than sequentially after it, and the closing timeline shrinks by two to three weeks. Founders who manage this process themselves consistently underestimate how long investor coordination takes, particularly where one or more prior investors are managed by a fund with its own internal investment committee approval requirement before they can confirm exercise or waiver.

One additional step that most closing checklists omit: confirm at term sheet stage that the current AoA reflects the pre-emption clause in the existing SHA. If it does not, the AoA amendment must be built into the closing deliverables for the current round, not deferred to the next.

A case study in waiver failure

A Bengaluru-based SaaS company raised a Seed round of ₹3 crore in 2022 from an angel fund registered under SEBI AIF Regulations. By 2025, the company had crossed ₹100 crore in ARR and was raising a Series A of ₹45 crore from a Tier-1 VC. The angel fund’s SHA gave them a pro-rata pre-emption right on all future rounds, with a 15-day notice period. The SHA pre-emption clause was not reflected in the company’s AoA, which had not been updated since incorporation.

The founders, managing the round themselves, passed the Section 62(1)(c) special resolution and sent allotment notices to the incoming Series A investor without first issuing a pre-emption notice to the angel fund. The angel fund, which had by then crossed its DPIIT eligibility window, could not legally exercise the right under the then-applicable SEBI position, but it had never been given the notice to make that election.

The angel fund raised a breach of SHA claim against the founders (not the company, since the pre-emption clause was not in the AoA). The dispute delayed the Series A closing by six weeks, required the founders to obtain a retroactive waiver letter with consideration paid, and created a governance record that the Series A investor’s counsel flagged during diligence. Fixing the AoA at the same time added another week to the process. The total cost, financial and reputational, far exceeded what a properly managed waiver process would have cost at the time of closing.

FAQ on pre-emptive rights in Indian funding rounds

Q: Do founders have pre-emptive rights in an Indian startup?
A: Founders who hold equity shares have statutory pre-emptive rights under Section 62(1)(a) of the Companies Act 2013. However, the standard SHA structure in Indian VC-backed companies grants pre-emption rights contractually to investors, not to founders. Whether founders are included in the SHA pre-emption clause depends on the negotiation. Most institutional investor SHAs do not grant founders contractual pre-emption rights.

Q: Can an investor waive pre-emptive rights permanently?
A: An investor can waive pre-emption rights on a transaction-specific basis. A permanent, advance waiver of all future pre-emption rights may not be enforceable under Indian contract law, particularly if it is not supported by consideration. The better drafting approach is a round-by-round waiver process, with the SHA’s non-response deemed-waiver mechanism as the default.

Q: What happens if the company allots shares without obtaining pre-emption waivers?
A: The allotment itself is not automatically void. Section 62(1)(c) compliance through a special resolution satisfies the statutory requirement. But an investor whose contractual SHA pre-emption rights were not observed can bring a breach of contract claim seeking damages, or, where the SHA pre-emption clause is also mirrored in the AoA, seek company-level remedies. This is why closing conditions in Indian SHAs almost always require pre-emption waivers as a condition to allotment.

Q: Is a pre-emption right the same as a right of first refusal?
A: No. A pre-emption right (or pro-rata right) relates to new share issuances by the company: it allows the holder to participate in new capital raises. A right of first refusal (ROFR) relates to existing share transfers: it requires a shareholder who wants to sell their shares to offer them first to other shareholders or the company before selling to a third party. The two rights address different transactions and are drafted as separate clauses in the SHA.

Q: Does the ESOP pool carve-out apply to all ESOP grants or only grants up to the approved pool?
A: The carve-out applies to grants made within the approved pool size as documented in the SHA. If the company creates a new ESOP pool or expands the existing pool beyond the approved size, that expansion may trigger pre-emption rights under some SHA drafts. The SHA should clearly define the approved pool size and state that grants within that pool do not trigger pre-emption.

Q: What is the difference between pro-rata rights and super pro-rata rights?
A: A pro-rata right allows an investor to maintain their current ownership percentage by subscribing to a proportional share of new securities. A super pro-rata right allows them to increase their ownership percentage in a new round, typically to a defined target percentage. Super pro-rata rights benefit the investor at the expense of founders and other shareholders, and should be resisted at term sheet stage.

Q: What does “fully diluted” mean for the purpose of calculating pre-emption entitlement?
A: Fully diluted capital includes all issued equity shares, all CCPS on an as-converted basis, all outstanding CCDs on an as-converted basis, all ESOP grants (both vested and unvested), and all outstanding warrants. The SHA should define this explicitly. A dispute over the fully diluted denominator can produce a material difference in each investor’s pre-emption entitlement, particularly in companies with large ESOP pools or convertible instrument histories.

Q: Can new investors negotiate for pre-emption rights in the same round?
A: Yes. A Series B investor who is taking a large stake will typically negotiate for pro-rata pre-emption rights in any subsequent Series C or later round. These are granted in the new SHA signed as part of the Series B closing. Series B investors with super pro-rata rights can significantly constrain the founders’ and Series A investors’ allocation flexibility in the Series C.

Q: How does SEBI’s September 2025 angel fund amendment affect pre-emption?
A: For angel funds registered under SEBI AIF Regulations, pre-emption rights can now be exercised in investee companies that have graduated beyond DPIIT startup status, but only to the extent that the fund’s shareholding percentage does not increase (it can maintain, not grow) and total investment in the investee company does not exceed ₹25 crore in aggregate. Angel funds that have already deployed ₹25 crore into a company cannot exercise further pre-emption rights regardless of what the SHA says.

Q: Is the pre-emption notice period under the SHA negotiable?
A: Yes. Most Indian SHAs specify a 10 to 20 day notice period. In time-sensitive rounds, founders should negotiate for the shorter end of that range at the term sheet stage, along with a clear definition of what constitutes adequate notice and what happens if an investor fails to respond.

Q: What if an investor wants to exercise only a partial pre-emption right?
A: Unless the SHA explicitly prohibits partial exercise, an investor can elect to exercise for a portion of their entitlement. The unexercised portion flows through the oversubscription mechanic first (to other exercising investors) and then to the incoming investor. Partial exercise is common where an investor wants to limit capital deployed in a given round but does not want to entirely forgo participation.

Q: Are pre-emption rights affected by a company converting to an LLP?
A: Pre-emption rights as structured in a private limited company SHA are specific to the company law framework. An LLP does not have shareholders. It has partners with contribution interests. Conversion requires renegotiating the entire governance framework, and pre-emption rights would need to be redesigned as pre-emption on new capital contributions, governed by the LLP agreement. Conversions of VC-backed companies to LLP structure are rare precisely because the investor rights framework does not map cleanly.

Q: What is the interaction between pre-emption rights and anti-dilution rights in a down round?
A: They are legally distinct but financially complementary. Anti-dilution adjusts the conversion ratio of existing CCPS upward in a down round, increasing the investor’s percentage mechanically without additional investment. Pre-emption rights allow the same investor to additionally acquire new shares at the lower down-round price. An investor exercising both in a down round can increase their ownership significantly at the expense of founders. Where a pay-to-play provision links the two, non-exercise of pre-emption also costs the investor their anti-dilution protection.

Q: What is the AoA mirroring requirement and why does it matter for pre-emption?
A: Indian courts including the Supreme Court in V.B. Rangaraj (1992) have held consistently that SHA provisions not reflected in the AoA are enforceable only between the SHA signatories, not against the company itself. A pre-emption clause in the SHA that is not mirrored in the AoA gives the investor a contractual claim against co-signatories if ignored, but does not give them a company-level remedy. They cannot compel the company to unwind an allotment or issue shares on the basis of the SHA alone. Pre-emption clauses must be incorporated into the AoA by special resolution at each funding round close.

Q: What FEMA filings are required when a foreign investor exercises a pre-emption right?
A: The exercise constitutes fresh FDI. Before allotment, the company must confirm sectoral cap headroom and obtain a fresh FMV valuation from a SEBI-registered Merchant Banker or CA. After the foreign investor remits funds through an AD bank and the FIRC is obtained, shares are allotted and Form FC-GPR must be filed on the RBI FIRMS portal within 30 days. The FLA return must be updated by 15 July of the relevant year. The same steps apply whether the foreign investor is exercising their own entitlement or receiving shares via renunciation from a resident shareholder, subject to the Rule 7A pricing norms in the renunciation scenario.

Q: What is renunciation and how does it differ from waiver?
A: Waiver means the pre-emption right holder declines to exercise, and their entitlement flows back into the pool for reallocation under the oversubscription mechanic. Renunciation under Section 62(1)(a)(ii) means the holder actively transfers their subscription entitlement to a named third party, who then subscribes in their own right. Renunciation to a non-resident triggers FEMA pricing norms under Rule 7A of the NDI Rules, unlike a standard rights issue which is exempt from pricing norms under Rule 7.